EGFR and hepatocellular carcinoma: About EGF, numerous studies have demonstrated its capacity of mediating the malignant biological behavior of HCC is reached through interacting with EGF receptor (EGFR) and activating specific oncogenic signaling pathways, like ERK and PI3K axis [45, 46].